Latest Releases
U.S. Senator Tina Smith’s Bills to Reduce the Cost of Prescription Drugs and Expand Access to Health Care Signed Into Law
WASHINGTON, D.C. [1/13/23] — More than half a dozen health care bills by U.S. Senator Tina Smith (D-Minn.) were signed into law by President Biden two weeks ago. The measures will take important steps to lower the cost of prescription drugs, address public health workforce shortages, and shore up supply chains while creating good-paying American jobs. Most of the provisions were bipartisan. “Since my first day in office, I’ve promised Minnesotans that I would work to reduce the cost of prescription drugs and expand access to health care,” said Sen. Smith. “These measures provide the tools to make significant progress on lowering health care costs, boosting our public health workforce, and more.” These new laws will: Require the Department of Health and Human Services (HHS) to establish a program to improve health outcomes and reduce health inequities. Help speed up the development of and improve access to lower-cost generic drugs by requiring the Food and Drug Administration (FDA) to make timely therapeutic equivalence evaluations for drugs approved through the complex generic pathway. This provision is based on Smith’s Modernizing Therapeutic Equivalence Rating Determination Act. Clarify the FDA’s ability to regulate combination products—products that meet both the definition of drugs and devices—as drugs rather than as devices. The provision is based on Smith’s Consistent Legal Evaluation and Regulation of Medical Products (CLEAR) Act and will eliminate unnecessary confusion and turmoil in the industry. This clarification will allow the FDA to spend more time and resources on bringing low-cost products to market to
U.S. Senator Tina Smith’s Bipartisan Mental Health Care Measures Signed Into Law
WASHINGTON, D.C. [1/13/23] — U.S. Senator Tina Smith (D-Minn.) announced two of her bipartisan mental health care bills were signed into law by President Biden two weeks ago. The provisions will take important steps to address the mental health crisis and improve Tribal health services. “I know firsthand the importance of mental health services. These measures will help expand access to mental health care in Minnesota and across this country,” said Sen. Smith. “It gives us the tools to make significant progress tackling the mental health crisis, upholding our commitments to Tribal Nations, and more.” Provisions based on Smith’s Improving Access to Behavioral Health Integration Act will provide funding for primary care practices to implement evidence-based behavioral health integration programs. In addition, the law will establish grants for Tribal governments, Tribal organizations, urban Indian organizations, and Tribal health programs to receive funds for culturally-competent mental and behavioral health services for Native Americans. The bills were included in the year-end government funding package that was recently signed into law. In addition to Smith’s mental health bills, the law also includes many other important provisions supported by Sen. Smith such as the Electoral Count Reform Act, support for the people of Ukraine, fully funding provisions of the PACT Act, permanently extending postpartum coverage for mothers on Medicaid and CHIP, increasing child care and housing access, and more.
U.S. Senators Klobuchar and Smith Urge Minnesota Dairy Farmers to Take Advantage of Extended Enrollment Deadline for Margin Protection Program
WASHINGTON, D.C. [09/23/2019]—Today, U.S. Senators Amy Klobuchar and Tina Smith (D-Minn.) are urging Minnesota dairy farmers to sign up for the Dairy Margin Coverage (DMC) program by the extended deadline of September 27. The Senators said that the DMC program offers protection to dairy producers when the difference between the all-milk price and the average feed cost (the margin) falls below a certain dollar amount selected by the producer. All dairy operations in Minnesota are eligible for the DMC program. “Over the past few years, dairy farmers have continued to face market instability and sustained low prices and they deserve our support during tough times like these,” Sen. Klobuchar said. “This sign-up
U.S. Senator Tina Smith Says Mayor Bob Anderson Was Dedicated to “Anything and Everything Connected to His Beloved International Falls”
MINNESOTA [09/20/19]—Today, U.S. Senator Tina Smith (D-Minn.) released the following statement about the passing of International Falls mayor Bob Anderson: “I am deeply saddened to hear about the passing of International Falls Mayor Bob Anderson. Mayor Anderson was passionate about his community and his love was reflected in his years of dedication to the airport, hospital, Highway 53 Task Force, the county, anything and everything connected to his beloved International Falls. I’m grateful I saw him just this August. He was a friend and I will miss seeing him when I visit the Borderland.”
U.S. Senator Tina Smith, Senate Colleagues Make Bipartisan Effort to Stop Deceptive Meat Labeling
WASHINGTON, D.C. [09/20/2019]—U.S. Senator Tina Smith (D-Minn.) is leading a bipartisan Senate effort to stop deceptive labeling practices that hurt bison ranchers and mislead consumers in Minnesota and across the country. This week, Sen. Smith and several Senate colleagues introduced the “Truth in Buffalo Labeling Act” that would allow the Food and Drug Administration (FDA) to prohibit water buffalo products from being marketed as “buffalo.” “Minnesota’s bison ranches are an important part of our farming economy,” said Sen. Smith. “Deceptive labeling not only hurts their bottom lines, but also misleads Minnesotans into purchasing and eating food that’s not necessarily what they think it is. This labeling fix will help ranchers and consumers alike.” “Minnesota
U.S. Senators Smith and Cramer Make Bipartisan Push to Hold Big Pharma Accountable, Have Execs Address Congress Directly About Skyrocketing Drug Prices
WASHINGTON, D.C. [09/17/2019]—Today U.S. Senators Tina Smith (D-Minn.) and Kevin Cramer (R-N.D.) urged the U.S. Senate Finance Committee to hold a hearing on their bipartisan bill to address the skyrocketing price of insulin and help people with diabetes access the life-saving medication they need to survive. The two lawmakers said that during the hearing they also hope to have pharmaceutical executives address Congress directly about high drug prices that are hurting many Americans. Approximately 7.5 million Americans with diabetes rely on insulin every day to survive yet the average price of insulin almost doubled between 2012 and 2016—forcing some patients into the dangerous practice
English